Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−4.87 USD
−7.78 M USD
27.65 K USD
1.87 M
About Zivo Bioscience, Inc.
Sector
Industry
CEO
John Bernard Payne
Website
Headquarters
Bloomfield Hills
Founded
1983
FIGI
BBG000BZDWR5
Zivo Bioscience, Inc. engages in the study, development, and commercialization of natural nutritional compounds and bioactive molecules. It offers proprietary algae strain, extracts and supernatants, and bioactive compounds. The company was founded by Howard R. Baer on March 28, 1983 and is headquartered in Bloomfield Hills, MI.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ZIVO is 18.70 USD — it has decreased by −0.52% in the past 24 hours. Watch Zivo Bioscience, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Zivo Bioscience, Inc. stocks are traded under the ticker ZIVO.
ZIVO stock has fallen by −2.66% compared to the previous week, the month change is a 22.88% rise, over the last year Zivo Bioscience, Inc. has showed a 1.78 K% increase.
ZIVO reached its all-time high on Feb 3, 2004 with the price of 3,695.26 USD, and its all-time low was 0.48 USD and was reached on Nov 29, 2023. View more price dynamics on ZIVO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ZIVO stock is 11.89% volatile and has beta coefficient of −0.07. Track Zivo Bioscience, Inc. stock price on the chart and check out the list of the most volatile stocks — is Zivo Bioscience, Inc. there?
Today Zivo Bioscience, Inc. has the market capitalization of 70.39 M, it has decreased by −2.10% over the last week.
Yes, you can track Zivo Bioscience, Inc. financials in yearly and quarterly reports right on TradingView.
Zivo Bioscience, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
ZIVO net income for the last quarter is −2.27 M USD, while the quarter before that showed −8.24 M USD of net income which accounts for 72.46% change. Track more Zivo Bioscience, Inc. financial stats to get the full picture.
No, ZIVO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 26, 2024, the company has 8.00 employees. See our rating of the largest employees — is Zivo Bioscience, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Zivo Bioscience, Inc. EBITDA is −13.66 M USD, and current EBITDA margin is −26.27 K%. See more stats in Zivo Bioscience, Inc. financial statements.
Like other stocks, ZIVO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Zivo Bioscience, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Zivo Bioscience, Inc. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Zivo Bioscience, Inc. stock shows the neutral signal. See more of Zivo Bioscience, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.